Empirical Wealth Management’s Akero Therapeutics AKRO Stock Holding History

Empirical Wealth Management’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-4,409	Closed	-$209K	–	899
2025 Q3	$209K	Buy	+4,409	New	+$213K	﹤0.01%	743

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Empirical Wealth Management's AKRO Position: Q4 2025 in Review

Empirical Wealth Management sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 4,409 shares — an estimated $209K sold.

Empirical Wealth Management first reported a position in AKRO in Q3 2025 and held it in 1 quarter. The position peaked at $209K in Q3 2025. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

Empirical Wealth Management reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
Empirical Wealth Management sold 4,409 Akero Therapeutics shares in Q4 2025, an estimated $209K.
Empirical Wealth Management first reported a position in Akero Therapeutics in Q3 2025 and held it in 1 quarter.
Empirical Wealth Management's Akero Therapeutics position peaked at $209K in Q3 2025.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on Empirical Wealth Management's 13F filing for Q4 2025, filed 16 Jan 2026.